XML 39 R28.htm IDEA: XBRL DOCUMENT v3.25.1
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Additional Information (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2025
USD ($)
customer
Dec. 31, 2024
USD ($)
Mar. 31, 2024
USD ($)
customer
Dec. 31, 2023
USD ($)
Mar. 31, 2025
USD ($)
customer
segment
Mar. 31, 2024
USD ($)
customer
Sep. 30, 2024
USD ($)
customer
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Net loss $ (3,336,120) $ (2,668,713) $ (4,493,783) $ (1,130,281) $ (6,004,833) $ (5,624,064)  
Operating cash flow         6,511,109    
Cash and cash equivalents 6,823,260       6,823,260   $ 6,431,095
Excess of FDIC insurance limit 6,700,000       $ 6,700,000    
Number of reportable segments | segment         3    
Transfers from Level 2 to Level 1, Assets 0       $ 0    
Transfers from Level 1 to Level 2, Assets 0       0    
Transfers from Level 2 to Level 1, Liabilities 0       0    
Transfers from Level 1 to Level 2, Liabilities $ 0       0    
Transfers Into Level 3, Liabilities         0    
Transfers out of Level 3, Liabilities         $ 0    
Customer Concentration Risk | Total Revenue | MDx Testing Services              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Number of customers | customer     1     1  
Customer Concentration Risk | Total Revenue | Therapeutic DNA Production              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Number of customers | customer     1     1  
Customer Concentration Risk | Total Revenue | Therapeutic DNA Production Services and MDx Testing Services segment              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Number of customers | customer 2            
Customer Concentration Risk | Total Revenue | DNA Tagging and Security Products and Services, MDx Testing Services and Therapeutic DNA Production Services              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Number of customers | customer         3    
Customer Concentration Risk | Total Revenue | One customer | MDx Testing Services              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Concentration risk percentage     24.00%     25.00%  
Customer Concentration Risk | Total Revenue | One customer | Therapeutic DNA Production              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Concentration risk percentage     28.00%     14.00%  
Customer Concentration Risk | Total Revenue | Two customers | MDx Testing Services              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Concentration risk percentage 15.00%            
Customer Concentration Risk | Total Revenue | Two customers | Therapeutic DNA Production              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Concentration risk percentage 34.00%            
Customer Concentration Risk | Total Revenue | Three customers | DNA Tagging and Security Products              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Concentration risk percentage         20.00%    
Customer Concentration Risk | Total Revenue | Three customers | MDx Testing Services              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Concentration risk percentage         17.00%    
Customer Concentration Risk | Total Revenue | Three customers | Therapeutic DNA Production              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Concentration risk percentage         15.00%    
Customer Concentration Risk | Accounts Receivable              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Number of customers | customer         4   3
Customer Concentration Risk | Accounts Receivable | Three customers              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Concentration risk percentage             60.00%
Customer Concentration Risk | Accounts Receivable | Four Customer              
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES              
Concentration risk percentage         79.00%